Invivyd (IVVD) Change in Acquisitions & Divestments (2021 - 2023)
Invivyd's (IVVD) quarterly Change in Acquisitions & Divestments came in at $77.9 million in Q4 2023, up 289.59% on a YoY basis from $20.0 million in Q4 2022, and down 18.1% quarter-over-quarter from $95.1 million in Q3 2023.
Analysis
Invivyd (IVVD) Change in Acquisitions & Divestments (2021 - 2023) Analysis & Trends
Invivyd (IVVD) has reported Change in Acquisitions & Divestments for 3 consecutive years, with $77.9 million the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Change in Acquisitions & Divestments rose 289.59% year-over-year to $77.9 million; the trailing twelve-month figure through Sep 2024 stood at $77.9 million (down 75.23% YoY), and the FY2023 full-year result was $372.5 million, up 439.86% from the prior year.
- Change in Acquisitions & Divestments fell to $77.9 million in Q4 2023 per IVVD's latest filing, from $95.1 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $138.0 million in Q4 2021 and bottomed at $20.0 million in Q4 2022.
- Historically, Change in Acquisitions & Divestments has averaged $82.8 million across 3 years, with a median of $77.9 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments plunged 85.51% in 2022, then soared 289.59% in 2023.
- Over 3 years, Change in Acquisitions & Divestments stood at $138.0 million in 2021, then slumped by 85.51% to $20.0 million in 2022, then jumped by 289.59% to $77.9 million in 2023.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $77.9 million, $95.1 million, and $123.8 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 77.92 Mn |
| Sep 30, 2023 | 95.14 Mn |
| Jun 30, 2023 | 123.79 Mn |
| Mar 31, 2023 | 75.66 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Mar 31, 2022 | 49.00 Mn |
| Dec 31, 2021 | 138.00 Mn |